Serious Side Effects: Pancreatitis: Rare (0.18%)
In total, however, the DPP-4 inhibitor class has demonstrated a good safety and tolerability spectrum that justifies the wide use of the class
Be Aware of Other Medications or Lifestyle Choices Before attributing every stomach upset to the GLP-1 medication, take a broader perspective
For anyone seeking the most evidence-supported, accessible anti-aging intervention, NAD+ precursor supplementation has a stronger foundation
However, because of the structural differences among different therapeutic GLP-1RAs, there is also a significant distinction in their stability, which affects their administration schedule, and thus they are often classified as either short- or long-acting
Watson K, Nasca C, Aasly L, McEwen B, Rasgon N (2018) Insulin resistance, an unmasked culprit in depressive disorders: promises for interventions